GlassScriptPhysician profile
Matthew Kyle Whitley
NPI 1689876872
$835.54
in general payments reported to CMS, 2019-2025
11 companies · $86.81 in 2025
The $86.81 reported for 2025 was less than what a typical Pediatric Otolaryngology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $43.21 · 2021: $168 · 2023: $311 · 2024: $52.01 · 2025: $86.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $449.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $272.70 | 2021-2023 | Stealthstation S8 Platform |
| Aerin Medical INC. | $188.59 | 2023 | |
| Karl Storz Endoscopy-America | $139.29 | 2019 | |
| Smith+Nephew, INC. | $42.69 | 2020-2025 | Coblation, Halo, Tula |
| Cochlear Americas | $36.08 | 2023-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Novartis Pharmaceuticals Corporation | $35.95 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $31.58 | 2025 | Dupixent |
| Advanced Bionics, LLC | $29.22 | 2020 | |
| Argenx US, INC. | $21.96 | 2025 | Vyvgart Hytrulo |
| Integra Lifesciences Corporation | $21.50 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Preceptis Medical, INC. | $15.98 | 2024 | Hummingbird Tympanostomy Tube System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Whitley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.